2aer

From Proteopedia

(Difference between revisions)
Jump to: navigation, search
(New page: 200px<br /> <applet load="2aer" size="450" color="white" frame="true" align="right" spinBox="true" caption="2aer, resolution 1.87&Aring;" /> '''Crystal Structure o...)
Line 1: Line 1:
-
[[Image:2aer.gif|left|200px]]<br />
+
[[Image:2aer.gif|left|200px]]<br /><applet load="2aer" size="350" color="white" frame="true" align="right" spinBox="true"
-
<applet load="2aer" size="450" color="white" frame="true" align="right" spinBox="true"
+
caption="2aer, resolution 1.87&Aring;" />
caption="2aer, resolution 1.87&Aring;" />
'''Crystal Structure of Benzamidine-Factor VIIa/Soluble Tissue Factor complex.'''<br />
'''Crystal Structure of Benzamidine-Factor VIIa/Soluble Tissue Factor complex.'''<br />
==Overview==
==Overview==
-
Factor VIIa (FVIIa) consists of a gamma-carboxyglutamic acid (Gla) domain, two epidermal growth factor-like domains, and a protease domain. FVIIa, binds seven Ca(2+) ions in the Gla, one in the EGF1, and one in the, protease domain. However, blood contains both Ca(2+) and Mg(2+), and the, Ca(2+) sites in FVIIa that could be specifically occupied by Mg(2+) are, unknown. Furthermore, FVIIa contains a Na(+) and two Zn(2+) sites, but, ligands for these cations are undefined. We obtained, p-aminobenzamidine-VIIa/soluble tissue factor (sTF) crystals under, conditions containing Ca(2+), Mg(2+), Na(+), and Zn(2+). The crystal, diffracted to 1.8A resolution, and the final structure has an R-factor of, 19.8%. In this structure, the Gla domain has four Ca(2+) and three bound, Mg(2+). The EGF1 domain contains one Ca(2+) site, and the protease domain, contains one Ca(2+), one Na(+), and two Zn(2+) sites. (45)Ca(2+) binding, in the presence/absence of Mg(2+) to FVIIa, Gla-domainless FVIIa, and, prothrombin fragment 1 supports the crystal data. Furthermore, unlike in, other serine proteases, the amide N of Gly(193) in FVIIa points away from, the oxyanion hole in this structure. Importantly, the oxyanion hole is, also absent in the benzamidine-FVIIa/sTF structure at 1.87A resolution., However, soaking benzamidine-FVIIa/sTF crystals with, d-Phe-Pro-Arg-chloromethyl ketone results in benzamidine displacement, d-Phe-Pro-Arg incorporation, and oxyanion hole formation by a flip of the, 192-193 peptide bond in FVIIa. Thus, it is the substrate and not the TF, binding that induces oxyanion hole formation and functional active site, geometry in FVIIa. Absence of oxyanion hole is unusual and has biologic, implications for FVIIa macromolecular substrate specificity and catalysis.
+
Factor VIIa (FVIIa) consists of a gamma-carboxyglutamic acid (Gla) domain, two epidermal growth factor-like domains, and a protease domain. FVIIa binds seven Ca(2+) ions in the Gla, one in the EGF1, and one in the protease domain. However, blood contains both Ca(2+) and Mg(2+), and the Ca(2+) sites in FVIIa that could be specifically occupied by Mg(2+) are unknown. Furthermore, FVIIa contains a Na(+) and two Zn(2+) sites, but ligands for these cations are undefined. We obtained p-aminobenzamidine-VIIa/soluble tissue factor (sTF) crystals under conditions containing Ca(2+), Mg(2+), Na(+), and Zn(2+). The crystal diffracted to 1.8A resolution, and the final structure has an R-factor of 19.8%. In this structure, the Gla domain has four Ca(2+) and three bound Mg(2+). The EGF1 domain contains one Ca(2+) site, and the protease domain contains one Ca(2+), one Na(+), and two Zn(2+) sites. (45)Ca(2+) binding in the presence/absence of Mg(2+) to FVIIa, Gla-domainless FVIIa, and prothrombin fragment 1 supports the crystal data. Furthermore, unlike in other serine proteases, the amide N of Gly(193) in FVIIa points away from the oxyanion hole in this structure. Importantly, the oxyanion hole is also absent in the benzamidine-FVIIa/sTF structure at 1.87A resolution. However, soaking benzamidine-FVIIa/sTF crystals with d-Phe-Pro-Arg-chloromethyl ketone results in benzamidine displacement, d-Phe-Pro-Arg incorporation, and oxyanion hole formation by a flip of the 192-193 peptide bond in FVIIa. Thus, it is the substrate and not the TF binding that induces oxyanion hole formation and functional active site geometry in FVIIa. Absence of oxyanion hole is unusual and has biologic implications for FVIIa macromolecular substrate specificity and catalysis.
==Disease==
==Disease==
Line 11: Line 10:
==About this Structure==
==About this Structure==
-
2AER is a [http://en.wikipedia.org/wiki/Protein_complex Protein complex] structure of sequences from [http://en.wikipedia.org/wiki/Homo_sapiens Homo sapiens] with GLC, FUC, MG, CA, NA, ZN, CL and BEN as [http://en.wikipedia.org/wiki/ligands ligands]. Active as [http://en.wikipedia.org/wiki/Coagulation_factor_VIIa Coagulation factor VIIa], with EC number [http://www.brenda-enzymes.info/php/result_flat.php4?ecno=3.4.21.21 3.4.21.21] Full crystallographic information is available from [http://ispc.weizmann.ac.il/oca-bin/ocashort?id=2AER OCA].
+
2AER is a [http://en.wikipedia.org/wiki/Protein_complex Protein complex] structure of sequences from [http://en.wikipedia.org/wiki/Homo_sapiens Homo sapiens] with <scene name='pdbligand=GLC:'>GLC</scene>, <scene name='pdbligand=FUC:'>FUC</scene>, <scene name='pdbligand=MG:'>MG</scene>, <scene name='pdbligand=CA:'>CA</scene>, <scene name='pdbligand=NA:'>NA</scene>, <scene name='pdbligand=ZN:'>ZN</scene>, <scene name='pdbligand=CL:'>CL</scene> and <scene name='pdbligand=BEN:'>BEN</scene> as [http://en.wikipedia.org/wiki/ligands ligands]. Active as [http://en.wikipedia.org/wiki/Coagulation_factor_VIIa Coagulation factor VIIa], with EC number [http://www.brenda-enzymes.info/php/result_flat.php4?ecno=3.4.21.21 3.4.21.21] Full crystallographic information is available from [http://oca.weizmann.ac.il/oca-bin/ocashort?id=2AER OCA].
==Reference==
==Reference==
Line 18: Line 17:
[[Category: Homo sapiens]]
[[Category: Homo sapiens]]
[[Category: Protein complex]]
[[Category: Protein complex]]
-
[[Category: Bajaj, M.S.]]
+
[[Category: Bajaj, M S.]]
-
[[Category: Bajaj, S.P.]]
+
[[Category: Bajaj, S P.]]
[[Category: Dumas, J.]]
[[Category: Dumas, J.]]
[[Category: Liesum, A.]]
[[Category: Liesum, A.]]
[[Category: Padmanabhan, K.]]
[[Category: Padmanabhan, K.]]
[[Category: Prevost, D.]]
[[Category: Prevost, D.]]
-
[[Category: Schmidt, A.E.]]
+
[[Category: Schmidt, A E.]]
[[Category: Schreuder, H.]]
[[Category: Schreuder, H.]]
[[Category: BEN]]
[[Category: BEN]]
Line 49: Line 48:
[[Category: zinc]]
[[Category: zinc]]
-
''Page seeded by [http://ispc.weizmann.ac.il/oca OCA ] on Mon Nov 12 20:49:55 2007''
+
''Page seeded by [http://oca.weizmann.ac.il/oca OCA ] on Thu Feb 21 16:26:37 2008''

Revision as of 14:26, 21 February 2008


2aer, resolution 1.87Å

Drag the structure with the mouse to rotate

Crystal Structure of Benzamidine-Factor VIIa/Soluble Tissue Factor complex.

Contents

Overview

Factor VIIa (FVIIa) consists of a gamma-carboxyglutamic acid (Gla) domain, two epidermal growth factor-like domains, and a protease domain. FVIIa binds seven Ca(2+) ions in the Gla, one in the EGF1, and one in the protease domain. However, blood contains both Ca(2+) and Mg(2+), and the Ca(2+) sites in FVIIa that could be specifically occupied by Mg(2+) are unknown. Furthermore, FVIIa contains a Na(+) and two Zn(2+) sites, but ligands for these cations are undefined. We obtained p-aminobenzamidine-VIIa/soluble tissue factor (sTF) crystals under conditions containing Ca(2+), Mg(2+), Na(+), and Zn(2+). The crystal diffracted to 1.8A resolution, and the final structure has an R-factor of 19.8%. In this structure, the Gla domain has four Ca(2+) and three bound Mg(2+). The EGF1 domain contains one Ca(2+) site, and the protease domain contains one Ca(2+), one Na(+), and two Zn(2+) sites. (45)Ca(2+) binding in the presence/absence of Mg(2+) to FVIIa, Gla-domainless FVIIa, and prothrombin fragment 1 supports the crystal data. Furthermore, unlike in other serine proteases, the amide N of Gly(193) in FVIIa points away from the oxyanion hole in this structure. Importantly, the oxyanion hole is also absent in the benzamidine-FVIIa/sTF structure at 1.87A resolution. However, soaking benzamidine-FVIIa/sTF crystals with d-Phe-Pro-Arg-chloromethyl ketone results in benzamidine displacement, d-Phe-Pro-Arg incorporation, and oxyanion hole formation by a flip of the 192-193 peptide bond in FVIIa. Thus, it is the substrate and not the TF binding that induces oxyanion hole formation and functional active site geometry in FVIIa. Absence of oxyanion hole is unusual and has biologic implications for FVIIa macromolecular substrate specificity and catalysis.

Disease

Known diseases associated with this structure: Esophageal squamous cell carcinoma OMIM:[606551], Factor VII deficiency OMIM:[227500], Myocardial infarction, decreased susceptibility to OMIM:[227500]

About this Structure

2AER is a Protein complex structure of sequences from Homo sapiens with , , , , , , and as ligands. Active as Coagulation factor VIIa, with EC number 3.4.21.21 Full crystallographic information is available from OCA.

Reference

High resolution structures of p-aminobenzamidine- and benzamidine-VIIa/soluble tissue factor: unpredicted conformation of the 192-193 peptide bond and mapping of Ca2+, Mg2+, Na+, and Zn2+ sites in factor VIIa., Bajaj SP, Schmidt AE, Agah S, Bajaj MS, Padmanabhan K, J Biol Chem. 2006 Aug 25;281(34):24873-88. Epub 2006 Jun 6. PMID:16757484

Page seeded by OCA on Thu Feb 21 16:26:37 2008

Proteopedia Page Contributors and Editors (what is this?)

OCA

Personal tools